DHA/Fe2+-doped porphyrin COFs enable ROS-amplified multimodal tumor therapy
Abstract
A porphyrin-based covalent organic framework system doped with Fe2+ and dihydroartemisinin (DHA) has been developed for enhanced antitumor therapy. This platform enables coordinated generation of reactive oxygen species (ROS) including DHA-derived radicals, Fe2+-driven chemodynamic therapy (CDT), and porphyrin-mediated photodynamic therapy (PDT), which collectively amplify oxidative stress and significantly improve therapeutic efficacy.
- This article is part of the themed collection: New Developments in Photofunctional Materials and Transformations

Please wait while we load your content...